July 01, 2025

Cough Syrup for Cognition Loss?

Once used for coughs, ambroxol is being investigated for Parkinson disease dementia. A new trial shows it is safe and biologically active, though cognitive benefits remain unproven.

Conexiant

July 01, 2025

Genetic Markers Differentiate Salivary Gland Tumors

Genetic and epigenetic profiling distinguish pleomorphic adenoma from carcinoma ex pleomorphic adenoma

The Pathologist

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

A Second Glance

An international research team challenges the main hypothesis regarding the evolution of human eye appearance

The Ophthalmologist

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Extended Follow-up of Belzutifan Treatment for von Hippel–Lindau Disease–Associated Renal Cell Carcinoma

In extended follow-up of the phase II LITESPARK-004 trial reported in The Lancet Oncology, Srinivasan et al looked at the use of belzutifan and outcomes in patients with von Hippel–Lindau disease-asso...

The ASCO Post

June 27, 2025

Ciltacabtagene Autoleucel Delivers Lasting Remissions in Relapsed or Refractory Multiple Myeloma

New long-term follow-up data from the phase Ib/II CARTITUDE-1 study demonstrated that one-third of patients in the study with relapsed or refractory multiple myeloma treated with ciltacabtagene autole...

The ASCO Post

June 27, 2025

Could Vertigo Be Signaling Something More?

Dizziness may be more than a balance issue—research links vestibular disorders to significantly increased mental health risks.

Conexiant

June 27, 2025

Novel BTK and BCL2 Inhibitors Redefine CLL Treatment Across Front-Line and Relapsed Settings

Two pivotal phase III trials presented at the 2024 ASH Annual Meeting & Exposition mark a significant shift toward chemotherapy-free approaches in chronic lymphocytic leukemia, offering potentiall...

The ASCO Post